Cargando…

Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia

Detalles Bibliográficos
Autores principales: Park, Sang Hyuk, Chi, Hyun-Sook, Kwon, Mi-Ryang, Cho, Young-Uk, Jang, Seongsoo, Park, Chan-Jeoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486944/
https://www.ncbi.nlm.nih.gov/pubmed/23130349
http://dx.doi.org/10.3343/alm.2012.32.6.452
_version_ 1782248420728111104
author Park, Sang Hyuk
Chi, Hyun-Sook
Kwon, Mi-Ryang
Cho, Young-Uk
Jang, Seongsoo
Park, Chan-Jeoung
author_facet Park, Sang Hyuk
Chi, Hyun-Sook
Kwon, Mi-Ryang
Cho, Young-Uk
Jang, Seongsoo
Park, Chan-Jeoung
author_sort Park, Sang Hyuk
collection PubMed
description
format Online
Article
Text
id pubmed-3486944
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Korean Society for Laboratory Medicine
record_format MEDLINE/PubMed
spelling pubmed-34869442012-11-05 Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia Park, Sang Hyuk Chi, Hyun-Sook Kwon, Mi-Ryang Cho, Young-Uk Jang, Seongsoo Park, Chan-Jeoung Ann Lab Med Letter to the Editor The Korean Society for Laboratory Medicine 2012-11 2012-10-17 /pmc/articles/PMC3486944/ /pubmed/23130349 http://dx.doi.org/10.3343/alm.2012.32.6.452 Text en © The Korean Society for Laboratory Medicine. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Park, Sang Hyuk
Chi, Hyun-Sook
Kwon, Mi-Ryang
Cho, Young-Uk
Jang, Seongsoo
Park, Chan-Jeoung
Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
title Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
title_full Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
title_fullStr Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
title_full_unstemmed Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
title_short Rare Frameshift Mutation Cys475Tyrfs(*)11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia
title_sort rare frameshift mutation cys475tyrfs(*)11 in the bcr/abl kinase domain contributes to imatinib mesylate resistance in 2 korean patients with chronic myelogenous leukemia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486944/
https://www.ncbi.nlm.nih.gov/pubmed/23130349
http://dx.doi.org/10.3343/alm.2012.32.6.452
work_keys_str_mv AT parksanghyuk rareframeshiftmutationcys475tyrfs11inthebcrablkinasedomaincontributestoimatinibmesylateresistancein2koreanpatientswithchronicmyelogenousleukemia
AT chihyunsook rareframeshiftmutationcys475tyrfs11inthebcrablkinasedomaincontributestoimatinibmesylateresistancein2koreanpatientswithchronicmyelogenousleukemia
AT kwonmiryang rareframeshiftmutationcys475tyrfs11inthebcrablkinasedomaincontributestoimatinibmesylateresistancein2koreanpatientswithchronicmyelogenousleukemia
AT choyounguk rareframeshiftmutationcys475tyrfs11inthebcrablkinasedomaincontributestoimatinibmesylateresistancein2koreanpatientswithchronicmyelogenousleukemia
AT jangseongsoo rareframeshiftmutationcys475tyrfs11inthebcrablkinasedomaincontributestoimatinibmesylateresistancein2koreanpatientswithchronicmyelogenousleukemia
AT parkchanjeoung rareframeshiftmutationcys475tyrfs11inthebcrablkinasedomaincontributestoimatinibmesylateresistancein2koreanpatientswithchronicmyelogenousleukemia